Allico Pharmaceutical Decides to Acquire Treasury Shares Worth 4.7 Billion KRW

[Asia Economy Reporter Minwoo Lee] Aliko Pharmaceutical announced on the 6th that it has decided to acquire 64,000 shares of its common stock worth 4.7 billion KRW on the market. The expected acquisition period is from the 7th to January 6, 2022. The company explained, "We decided to acquire treasury shares to stabilize the stock price and enhance shareholder value."